Centiva Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,500
| Closed | -$1.05M | – | 1545 |
|
|
2025
Q1 | $1.05M | Buy |
+9,500
| New | +$1.05M | 0.03% | 363 |
|
|
2024
Q4 | – | Sell |
-2,079
| Closed | -$240K | – | 1665 |
|
|
2024
Q3 | $240K | Sell |
2,079
-742
| -26% | -$85.5K | ﹤0.01% | 1206 |
|
|
2024
Q2 | $388K | Buy |
+2,821
| New | +$388K | 0.01% | 909 |
|